Alzheimer’s disease: unraveling role of xanthone derivatives and nanocarriers

This publication has 100 references indexed in Scilit:

• Berberine chloride loaded nano‐ PEGylated liposomes attenuates imidacloprid‐induced neurotoxicity by inhibiting NLRP3 /Caspase‐1/ GSDMD ‐mediated pyroptosis
  BioFactors, 2024
• Beyond lecanemab: Examining Phase III potential in Alzheimer's therapeutics
  Psychiatry and Clinical Neurosciences Reports, 2024
• The mechanisms of action of prenylated xanthones against breast, colon, and lung cancers, and their potential application against drug resistance
  Phytochemistry Reviews, 2022
• Recently Approved Alzheimer Drug Raises Questions That Might Never Be Answered
  JAMA, 2021
• Natural Xanthone α‐Mangostin Inhibits LPS‐Induced Microglial Inflammatory Responses and Memory Impairment by Blocking the TAK1/NF‐κB Signaling Pathway
  Molecular Nutrition & Food Research, 2020
• Gartanin Protects Neurons against Glutamate-Induced Cell Death in HT22 Cells: Independence of Nrf-2 but Involvement of HO-1 and AMPK
  Neurochemical Research, 2016
• Natural Xanthones from Garcinia mangostana with Multifunctional Activities for the Therapy of Alzheimer’s Disease
  Neurochemical Research, 2016
• Structure–activity relationship study of secondary metabolites from Mesua beccariana, Mesua ferrea and Mesua congestiflora for anti-cholinesterase activity
  Medicinal Chemistry Research, 2016
• Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders
  Phytotherapy Research, 2009
• Garcinia mangostana L.: a phytochemical and pharmacological review
  Phytotherapy Research, 2009